Ackermans & van Haaren: Acquisition of boutique wealth manager Petram & Co. Alfen: Takes care of costs and debt, guidance misses. Arcadis: Solid backlog growth provides comfort. BAM: A friend of ours, 10% yield. CM.com: 2H24 results – FCF positive, capital restructuring. dsm-firmenich: Cash in, cash back. Flow Traders: Roller Coaster. KBC: Encouraging outlook to 2027, poor dividend. RELX: FY24 results – in line, £1.5bn buyback in 2025. Talabat: A beat at its maiden 4Q24 results...
We have updated our Unilever forecasts to account for lower-than-expected price inflation and the recent weakness of the Euro. The net result is that our EPS forecast for 2024F is almost unchanged while our EPS forecast for 2025F declines by 5%. We maintain our 12-month target price of €58.90 and BUY recommendation.
Summary Marketline's Orkla ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Orkla ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a...
>According to a FT article, an IPO is the most likely exit option - According to the Financial Times, Unilever has put an end to discussions with private equity funds on the disposal of the ice cream business. The plan is still an exit by the end of 2025 and a spin-off through an IPO is reportedly the most likely option. Last but not least, the FT article says that a € 10bn to € 15bn valuation for this business remains a credible range according to people close to th...
>According to a FT article, an IPO is the most likely exit option - According to the Financial Times, Unilever has put an end to discussions with private equity funds on the disposal of the ice cream business. The plan is still an exit by the end of 2025 and a spin-off through an IPO is reportedly the most likely option. Last but not least, the FT article says that a € 10bn to € 15bn valuation for this business remains a credible range according to people close to th...
>Q3 sales slightly below in reported terms - Unilever released Q3 sales of € 15,246m, flat vs Q3 2023 and vs the VA consensus at +1.2%. The gap comes from a more-negative-than expected FX impact (-2.8% vs css at -2.0%) and scope effect (-1.5% vs css at -0.7%). Nevertheless, the organic sales growth of 4.5% is better than expected (VA css at 4.1% and ODDO BHF at 3.4%) with a price effect of 0.9% that is in line but a volume/mix of 3.6% that is better (VA css at 3...
>Q3 sales slightly below in reported terms - Unilever released Q3 sales of € 15,246m, flat vs Q3 2023 and vs the VA consensus at +1.2%. The gap comes from a more-negative-than expected FX impact (-2.8% vs css at -2.0%) and scope effect (-1.5% vs css at -0.7%). Nevertheless, the organic sales growth of 4.5% is better than expected (VA css at 4.1% and ODDO BHF at 3.4%) with a price effect of 0.9% that is in line but a volume/mix of 3.6% that is better (VA css at 3...
Acomo: Hot Chocolate. Azelis: 3Q24 not flawless, but organic growth is back. BE Semiconductor Industries: 3Q24 results, putting its money where its mouth is. Ebusco: Rigorous turnaround plan, but many liquidity related concerns; recommendation moves to Under Review. GBL: Looking to take vitamins. Kinepolis: Solid 3Q24 attendance, in line, confident in the movie outlook for 4Q24, 2025. Ontex: Guidance Stumble. Unilever: Momentum maintained. Vastned: End of the disposal program, wa...
A director at Unilever Plc sold 5,170 shares at 4,988p and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Aalberts: Numbers broadly in line with expectations. Air France-KLM: Costs hurt. Arcadis: Nice beat in 2Q24 and good prospects to continue. BAM: Strong EBITDA, cash flow somewhat weak. BE Semiconductor Industries: 2Q24 results; High-end offsets mainstream. Econocom: Large 1H24 miss, change in management, governance. UCB: Strong 1H24 with slight increase in FY revenue guidance. Unilever: Steadfast. Universal Music Group: Okay headline figures cannot hide serious questions for music label...
Unilever has reported strong H1 2024 results this morning. Although growth was generally in line with expectations, the key takeaway came from the massive underlying operating margin improvement (+250bps) leading to a significant margin guidance upgrade. Just over a year after Hein Schumacher joine
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.